309 related articles for article (PubMed ID: 24862255)
1. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
Sarchielli P; Messina P; Cupini LM; Tedeschi G; Di Piero V; Livrea P; Pini LA; Bernardi G; Bono G; Sandrini G; Caproni S; Corbelli I; Pisani F; Beghi E; Calabresi P;
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1289-97. PubMed ID: 24862255
[TBL] [Abstract][Full Text] [Related]
2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.
Friedman BW; Garber L; Yoon A; Solorzano C; Wollowitz A; Esses D; Bijur PE; Gallagher EJ
Neurology; 2014 Mar; 82(11):976-83. PubMed ID: 24523483
[TBL] [Abstract][Full Text] [Related]
6. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
7. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial.
Mazaheri S; Poorolajal J; Hosseinzadeh A; Fazlian MM
PLoS One; 2015; 10(3):e0120229. PubMed ID: 25793707
[TBL] [Abstract][Full Text] [Related]
9. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
Tanen DA; Miller S; French T; Riffenburgh RH
Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
[TBL] [Abstract][Full Text] [Related]
10. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
11. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
Jensen R; Brinck T; Olesen J
Neurology; 1994 Apr; 44(4):647-51. PubMed ID: 8164818
[TBL] [Abstract][Full Text] [Related]
12. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
Stillman MJ; Zajac D; Rybicki LA
Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
17. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
18. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
[TBL] [Abstract][Full Text] [Related]
19. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
20. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]